Hsbc Holdings PLC Galera Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.34 - $1.76 $581 - $763	-434 Reduced 3.52%	11,901 $17,000
Q3 2022 Nov 14, 2022	SELL	$1.15 - $2.1 $633 - $1,157	-551 Reduced 4.28%	12,335 $21,000
Q2 2022 Aug 11, 2022	SELL	$1.24 - $2.39 $188 - $363	-152 Reduced 1.17%	12,886 $17,000
Q2 2021 Aug 13, 2021	BUY	$6.08 - $10.44 $48 - $83	8 Added 0.06%	13,038 $128,000
Q1 2021 May 14, 2021	SELL	$8.35 - $12.39 $2,037 - $3,023	-244 Reduced 1.84%	13,030 $114,000

Q4 2020 Feb 12, 2021	BUY	$8.02 - $12.81 $106,457 - $170,039	13,274 New	13,274 $135,000

10.7M

10.3K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $3.76M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.